Innovation in action

Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, startup companies, business ventures and equity investments.

Below is a small sampling.

Impact stories

Mayo Score for Ulcerative Colitis

Tool uncovering new treatment options.

Best Next Drug Migraine Algorithm

Using AI to make migraine expertise more accessible.

AI-assisted heart failure screening

New FDA-approved echocardiogram model used to detect disease.

Microvessel cancer diagnostic

Using high-definition ultrasound imaging to accurately diagnose cancer.

Platform therapy PMM2-CDG

Discovery leads to life-changing treatment for young girl with ultra-rare disease.

Stem cell therapy

For perianal fistulas in patients with Crohn’s disease.

Collaborating for cures

Taking research discoveries from bench to bedside.

Oncolytic virus therapies

Sodium-Iodide Symporter reporter gene imaging system.

Phage therapy treatment

Using viruses to target and kill specific bacteria.

Evolving vaccine efforts

Single-cycle adenovirus vaccine platform.

Cancer screening revolution

FDA-approved noninvasive colorectal screening.

Remote ECG patient monitoring

FDA-approved remote heart monitoring device.

Magnetic Resonance Elastography

Imaging tool for diagnosing liver fibrosis.